A handful of startups are employing artificial intelligence technologies and big data in an attempt to diagnose dementia, particularly Alzheimer’s disease. The effort could lead to better interventions and even therapeutic drugs if it becomes possible to detect cognitive decline before it really starts.

The benefits to society – not to mention market potential – for the early detection of dementia anId Alzheimer’s disease are huge. According to the World Health Organization, there were 47.5 million people worldwide with dementia in 2015, with 7.7 million new cases each year. The total number of people with dementia is projected to reach 75.6 million in 2030 and almost triple by 2050 to 135.5 million. There are nearly 500 open studies on Alzheimer’s disease alone, according to ClinicalTrials.gov.

NOTICE: The Certifications conferred by the NCBAC™ (Certified Alzheimer Caregiver™ "CAC™" and Certified Alzheimer Educator™ "CAEd™") are important indicators of quality care. The NCBAC™ does not license, approve nor bestow authorization to anyone the right to practice healthcare where such license or certification is regulated by any state, municipality or other government entity.